- United States
- /
- Banks
- /
- NasdaqCM:BAFN
BayFirst Financial Second Quarter 2025 Earnings: US$0.39 loss per share (vs US$0.12 profit in 2Q 2024)
BayFirst Financial (NASDAQ:BAFN) Second Quarter 2025 Results
Key Financial Results
- Revenue: US$15.9m (down 11% from 2Q 2024).
- Net loss: US$1.62m (down by 431% from US$490.0k profit in 2Q 2024).
- US$0.39 loss per share (down from US$0.12 profit in 2Q 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period
BayFirst Financial shares are down 22% from a week ago.
Risk Analysis
It's necessary to consider the ever-present spectre of investment risk. We've identified 2 warning signs with BayFirst Financial (at least 1 which is a bit concerning), and understanding these should be part of your investment process.
Valuation is complex, but we're here to simplify it.
Discover if BayFirst Financial might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NasdaqCM:BAFN
BayFirst Financial
Operates as the bank holding company for BayFirst National Bank that provides community banking services for small and medium sized businesses and individuals.
Flawless balance sheet and good value.
Market Insights
Weekly Picks

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

Adobe: A Probabilistic Case for Undervaluation

A Capital Allocation Favorite with Structural Importance

Good foundation, but now it's all about the next steps
Recently Updated Narratives

An Overlooked AI Play That’s Quietly Building a Healthcare Data Empire
Undervalued, Underestimated
Tanco's Pullback Brings Key Accumulation Zones Into Focus
Popular Narratives

Investment Analysis (May 2026)

Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026

Honeywell - The Demand-Side of the AI Infrastructure
Trending Discussion
It's wonderful. It has greatly helped me take informed decisions.

